PDB Short entry for 4GQL HEADER HYDROLASE/HYDROLASE INHIBITOR 23-AUG-12 4GQL TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN MMP12 IN COMPLEX TITLE 2 WITH SELECTIVE PHOSPHINIC INHIBITOR RXP470.1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MACROPHAGE METALLOELASTASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN (UNP RESIDUES 106-263); COMPND 5 SYNONYM: MME, MACROPHAGE ELASTASE, ME, HME, MATRIX METALLOPROTEINASE- COMPND 6 12, MMP-12; COMPND 7 EC: 3.4.24.65; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HME, MMP12; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET24A KEYWDS POTENT SELECTIVE PHOSPHINIC INHIBITOR, METZINCIN, ZINC PROTEASE, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR E.A.STURA,L.VERA,F.BEAU,L.DEVEL,E.CASSAR-LAJEUNESSE,V.DIVE REVDAT 3 13-SEP-23 4GQL 1 REMARK SEQADV LINK REVDAT 2 22-MAY-13 4GQL 1 JRNL REVDAT 1 06-FEB-13 4GQL 0 JRNL AUTH B.CZARNY,E.A.STURA,L.DEVEL,L.VERA,E.CASSAR-LAJEUNESSE, JRNL AUTH 2 F.BEAU,V.CALDERONE,M.FRAGAI,C.LUCHINAT,V.DIVE JRNL TITL MOLECULAR DETERMINANTS OF A SELECTIVE MATRIX JRNL TITL 2 METALLOPROTEASE-12 INHIBITOR: INSIGHTS FROM CRYSTALLOGRAPHY JRNL TITL 3 AND THERMODYNAMIC STUDIES. JRNL REF J.MED.CHEM. V. 56 1149 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23343195 JRNL DOI 10.1021/JM301574D REMARK 2 REMARK 2 RESOLUTION. 1.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8_1069) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.60 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.990 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 57994 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.134 REMARK 3 R VALUE (WORKING SET) : 0.133 REMARK 3 FREE R VALUE : 0.155 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2900 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.6125 - 3.1719 0.85 2449 129 0.1504 0.1702 REMARK 3 2 3.1719 - 2.5179 0.99 2732 144 0.1276 0.1492 REMARK 3 3 2.5179 - 2.1997 1.00 2684 142 0.1189 0.1331 REMARK 3 4 2.1997 - 1.9986 1.00 2695 141 0.1119 0.1236 REMARK 3 5 1.9986 - 1.8554 1.00 2670 141 0.1108 0.1214 REMARK 3 6 1.8554 - 1.7460 1.00 2636 139 0.1091 0.1279 REMARK 3 7 1.7460 - 1.6586 1.00 2664 140 0.1061 0.1249 REMARK 3 8 1.6586 - 1.5864 1.00 2654 140 0.1016 0.1416 REMARK 3 9 1.5864 - 1.5253 1.00 2649 139 0.0982 0.1260 REMARK 3 10 1.5253 - 1.4727 1.00 2634 139 0.1065 0.1338 REMARK 3 11 1.4727 - 1.4266 1.00 2628 138 0.1081 0.1307 REMARK 3 12 1.4266 - 1.3859 1.00 2648 139 0.1182 0.1495 REMARK 3 13 1.3859 - 1.3494 1.00 2638 139 0.1261 0.1409 REMARK 3 14 1.3494 - 1.3164 1.00 2606 137 0.1386 0.1624 REMARK 3 15 1.3164 - 1.2865 1.00 2631 139 0.1642 0.1911 REMARK 3 16 1.2865 - 1.2591 1.00 2649 139 0.1761 0.2652 REMARK 3 17 1.2591 - 1.2340 1.00 2593 137 0.1946 0.2375 REMARK 3 18 1.2340 - 1.2107 1.00 2638 138 0.2176 0.2582 REMARK 3 19 1.2107 - 1.1890 1.00 2613 137 0.2202 0.2341 REMARK 3 20 1.1890 - 1.1689 1.00 2641 139 0.2520 0.2320 REMARK 3 21 1.1689 - 1.1500 0.91 2342 124 0.3120 0.3186 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.110 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 15.160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.93 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 1517 REMARK 3 ANGLE : 1.500 2081 REMARK 3 CHIRALITY : 0.112 200 REMARK 3 PLANARITY : 0.007 275 REMARK 3 DIHEDRAL : 15.377 548 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4GQL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-SEP-12. REMARK 100 THE DEPOSITION ID IS D_1000074514. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979300 REMARK 200 MONOCHROMATOR : HORIZONTALLY DIFFRACTING SI REMARK 200 (111) MONOCHROMATOR AND PT REMARK 200 COATED MIRRORS IN KIRKPATRICK- REMARK 200 BAEZ GEOMETRY FOR FOCUSING REMARK 200 OPTICS : BENT CYLINDRICAL MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58014 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.150 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : 0.08400 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.7800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.5 REMARK 200 DATA REDUNDANCY IN SHELL : 6.73 REMARK 200 R MERGE FOR SHELL (I) : 1.30000 REMARK 200 R SYM FOR SHELL (I) : 1.20000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3TSK REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.31 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR: 25% PEG 10000, 0.2M REMARK 280 IMIDAZOLE MALATE. CRYOPROTECTANT: 27% PEG 8000, 15% MPEG 550, 10% REMARK 280 GLYCEROL, .01M HYDROXAMIC ACID, 90MM TRIS-HCL, PH 8.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 8.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 34.79000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.69500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.79000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.69500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 655 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 206 -152.64 -131.67 REMARK 500 HIS A 206 -134.97 -145.36 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 304 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 124 OD2 REMARK 620 2 ASP A 124 OD1 52.2 REMARK 620 3 GLU A 199 O 138.2 160.4 REMARK 620 4 GLU A 199 OE2 85.2 85.2 80.2 REMARK 620 5 GLU A 201 O 76.6 123.0 75.7 116.9 REMARK 620 6 HOH A 424 O 97.5 85.4 106.2 165.7 77.3 REMARK 620 7 HOH A 436 O 137.6 85.6 80.8 87.5 141.9 81.1 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 303 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 158 O REMARK 620 2 GLY A 190 O 166.9 REMARK 620 3 GLY A 192 O 94.0 93.5 REMARK 620 4 ASP A 194 OD2 87.9 103.3 86.9 REMARK 620 5 HOH A 417 O 81.9 88.7 169.1 103.0 REMARK 620 6 HOH A 423 O 83.8 87.0 79.8 163.7 89.7 REMARK 620 7 HOH A 648 O 113.7 65.5 140.9 68.1 49.3 128.2 REMARK 620 N 1 2 3 4 5 6 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 302 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 168 NE2 REMARK 620 2 ASP A 170 OD1 108.5 REMARK 620 3 HIS A 183 NE2 122.7 108.1 REMARK 620 4 HIS A 183 NE2 116.8 118.7 10.6 REMARK 620 5 HIS A 196 ND1 109.5 96.9 108.1 104.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA A 305 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 175 OD2 REMARK 620 2 GLY A 176 O 84.4 REMARK 620 3 GLY A 178 O 83.9 89.6 REMARK 620 4 ILE A 180 O 91.7 175.9 91.0 REMARK 620 5 ASP A 198 OD1 97.4 88.5 177.6 91.0 REMARK 620 6 GLU A 201 OE2 173.9 94.9 90.1 89.1 88.6 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 218 NE2 REMARK 620 2 HIS A 222 NE2 102.6 REMARK 620 3 HIS A 228 NE2 112.4 105.7 REMARK 620 4 R47 A 306 O2 115.8 120.3 99.8 REMARK 620 5 R47 A 306 O2 115.8 120.4 99.8 0.1 REMARK 620 N 1 2 3 4 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-[(2S)-3-[(S)-(4-BROMOPHENYL)(HYDROXY)PHOSPHORYL]- REMARK 630 2-{[3-(3'-CHLOROBIPHENYL-4-YL)-1,2-OXAZOL-5-YL]METHYL}PROPANOYL]-L- REMARK 630 ALPHA-GLUTAMYL-L-ALPHA-GLUTAMINE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 R47 A 306 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: 0YL GLU GLU NH2 REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE R47 A 306 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LIK RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3TS4 RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR REMARK 900 RELATED ID: 3TSK RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR REMARK 900 RELATED ID: 4EFS RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH L-GLUTAMATE MOTIF INHIBITOR REMARK 900 RELATED ID: 3LIL RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LIR RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 3LJG RELATED DB: PDB REMARK 900 HUMAN MMP12 IN COMPLEX WITH NON-ZINC CHELATING INHIBITOR REMARK 900 RELATED ID: 4GR0 RELATED DB: PDB REMARK 900 RELATED ID: 4GR3 RELATED DB: PDB REMARK 900 RELATED ID: 4GR8 RELATED DB: PDB DBREF 4GQL A 106 263 UNP P39900 MMP12_HUMAN 106 263 SEQADV 4GQL MET A 105 UNP P39900 INITIATING METHIONINE SEQADV 4GQL ASP A 171 UNP P39900 PHE 171 ENGINEERED MUTATION SEQRES 1 A 159 MET GLY PRO VAL TRP ARG LYS HIS TYR ILE THR TYR ARG SEQRES 2 A 159 ILE ASN ASN TYR THR PRO ASP MET ASN ARG GLU ASP VAL SEQRES 3 A 159 ASP TYR ALA ILE ARG LYS ALA PHE GLN VAL TRP SER ASN SEQRES 4 A 159 VAL THR PRO LEU LYS PHE SER LYS ILE ASN THR GLY MET SEQRES 5 A 159 ALA ASP ILE LEU VAL VAL PHE ALA ARG GLY ALA HIS GLY SEQRES 6 A 159 ASP ASP HIS ALA PHE ASP GLY LYS GLY GLY ILE LEU ALA SEQRES 7 A 159 HIS ALA PHE GLY PRO GLY SER GLY ILE GLY GLY ASP ALA SEQRES 8 A 159 HIS PHE ASP GLU ASP GLU PHE TRP THR THR HIS SER GLY SEQRES 9 A 159 GLY THR ASN LEU PHE LEU THR ALA VAL HIS GLU ILE GLY SEQRES 10 A 159 HIS SER LEU GLY LEU GLY HIS SER SER ASP PRO LYS ALA SEQRES 11 A 159 VAL MET PHE PRO THR TYR LYS TYR VAL ASP ILE ASN THR SEQRES 12 A 159 PHE ARG LEU SER ALA ASP ASP ILE ARG GLY ILE GLN SER SEQRES 13 A 159 LEU TYR GLY HET ZN A 301 1 HET ZN A 302 1 HET CA A 303 1 HET CA A 304 1 HET CA A 305 1 HET R47 A 306 134 HETNAM ZN ZINC ION HETNAM CA CALCIUM ION HETNAM R47 N-[(2S)-3-[(S)-(4-BROMOPHENYL)(HYDROXY)PHOSPHORYL]-2- HETNAM 2 R47 {[3-(3'-CHLOROBIPHENYL-4-YL)-1,2-OXAZOL-5- HETNAM 3 R47 YL]METHYL}PROPANOYL]-L-ALPHA-GLUTAMYL-L-ALPHA- HETNAM 4 R47 GLUTAMINE HETSYN R47 RXP470.1 FORMUL 2 ZN 2(ZN 2+) FORMUL 4 CA 3(CA 2+) FORMUL 7 R47 C35 H35 BR CL N4 O10 P FORMUL 8 HOH *303(H2 O) HELIX 1 1 ASN A 126 ASN A 143 1 18 HELIX 2 2 LEU A 212 LEU A 224 1 13 HELIX 3 3 ASP A 244 PHE A 248 5 5 HELIX 4 4 SER A 251 TYR A 262 1 12 SHEET 1 A 5 LYS A 148 LYS A 151 0 SHEET 2 A 5 TYR A 113 ILE A 118 1 N ILE A 114 O LYS A 148 SHEET 3 A 5 ILE A 159 ALA A 164 1 O VAL A 161 N ARG A 117 SHEET 4 A 5 ALA A 195 ASP A 198 1 O PHE A 197 N VAL A 162 SHEET 5 A 5 ALA A 182 ALA A 184 -1 N HIS A 183 O HIS A 196 SHEET 1 B 2 TRP A 203 THR A 204 0 SHEET 2 B 2 THR A 210 ASN A 211 1 O THR A 210 N THR A 204 LINK OD2 ASP A 124 CA CA A 304 1555 1555 2.39 LINK OD1 ASP A 124 CA CA A 304 1555 1555 2.58 LINK O ASP A 158 CA CA A 303 1555 1555 2.31 LINK NE2 HIS A 168 ZN ZN A 302 1555 1555 2.02 LINK OD1 ASP A 170 ZN ZN A 302 1555 1555 1.98 LINK OD2 ASP A 175 CA CA A 305 1555 1555 2.30 LINK O GLY A 176 CA CA A 305 1555 1555 2.28 LINK O GLY A 178 CA CA A 305 1555 1555 2.32 LINK O ILE A 180 CA CA A 305 1555 1555 2.32 LINK NE2AHIS A 183 ZN ZN A 302 1555 1555 2.01 LINK NE2BHIS A 183 ZN ZN A 302 1555 1555 2.05 LINK O GLY A 190 CA CA A 303 1555 1555 2.28 LINK O GLY A 192 CA CA A 303 1555 1555 2.29 LINK OD2 ASP A 194 CA CA A 303 1555 1555 2.43 LINK ND1 HIS A 196 ZN ZN A 302 1555 1555 2.04 LINK OD1 ASP A 198 CA CA A 305 1555 1555 2.31 LINK O GLU A 199 CA CA A 304 1555 1555 2.36 LINK OE2 GLU A 199 CA CA A 304 1555 1555 2.38 LINK O GLU A 201 CA CA A 304 1555 1555 2.40 LINK OE2 GLU A 201 CA CA A 305 1555 1555 2.25 LINK NE2 HIS A 218 ZN ZN A 301 1555 1555 2.02 LINK NE2 HIS A 222 ZN ZN A 301 1555 1555 2.02 LINK NE2 HIS A 228 ZN ZN A 301 1555 1555 2.01 LINK ZN ZN A 301 O2 BR47 A 306 1555 1555 1.83 LINK ZN ZN A 301 O2 AR47 A 306 1555 1555 1.83 LINK CA CA A 303 O HOH A 417 1555 1555 2.26 LINK CA CA A 303 O HOH A 423 1555 1555 2.36 LINK CA CA A 303 O HOH A 648 1555 1555 3.02 LINK CA CA A 304 O HOH A 424 1555 1555 2.39 LINK CA CA A 304 O HOH A 436 1555 1555 2.40 CISPEP 1 MET A 105 GLY A 106 0 9.97 SITE 1 AC1 4 HIS A 218 HIS A 222 HIS A 228 R47 A 306 SITE 1 AC2 4 HIS A 168 ASP A 170 HIS A 183 HIS A 196 SITE 1 AC3 7 ASP A 158 GLY A 190 GLY A 192 ASP A 194 SITE 2 AC3 7 HOH A 417 HOH A 423 HOH A 648 SITE 1 AC4 5 ASP A 124 GLU A 199 GLU A 201 HOH A 424 SITE 2 AC4 5 HOH A 436 SITE 1 AC5 6 ASP A 175 GLY A 176 GLY A 178 ILE A 180 SITE 2 AC5 6 ASP A 198 GLU A 201 SITE 1 AC6 41 THR A 154 GLY A 155 HIS A 172 GLY A 178 SITE 2 AC6 41 GLY A 179 ILE A 180 LEU A 181 ALA A 182 SITE 3 AC6 41 HIS A 183 THR A 215 HIS A 218 GLU A 219 SITE 4 AC6 41 HIS A 222 HIS A 228 PRO A 232 LYS A 233 SITE 5 AC6 41 ALA A 234 VAL A 235 PHE A 237 THR A 239 SITE 6 AC6 41 TYR A 240 LYS A 241 VAL A 243 PHE A 248 SITE 7 AC6 41 ZN A 301 HOH A 401 HOH A 421 HOH A 462 SITE 8 AC6 41 HOH A 469 HOH A 479 HOH A 489 HOH A 501 SITE 9 AC6 41 HOH A 504 HOH A 505 HOH A 573 HOH A 581 SITE 10 AC6 41 HOH A 609 HOH A 618 HOH A 630 HOH A 667 SITE 11 AC6 41 HOH A 703 CRYST1 69.580 63.390 36.900 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014372 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015775 0.000000 0.00000 SCALE3 0.000000 0.000000 0.027100 0.00000